Ingrida Balnyte
Overview
Explore the profile of Ingrida Balnyte including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
136
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zubritskiy A, Balnyte I, Fricke T, Konstantinov I
J Med Biogr
. 2024 Oct;
:9677720241285499.
PMID: 39469988
Vera Mikhailovna Danchakova (1877-1950), also written in English as Danchakoff and in German as Dantschakoff, was the first woman to graduate with a PhD in Russia. She was a person...
2.
Jukneviciene M, Balnyte I, Valanciute A, Alonso M, Preiksaitis A, Suziedelis K, et al.
Biomedicines
. 2024 Jul;
12(7).
PMID: 39061990
Valproic acid (VPA) has anticancer, anti-inflammatory, and epigenetic effects. The study aimed to determine the expression of carcinogenesis-related , , , and in adult glioblastoma U87 MG and T98G cells...
3.
Stakisaitis D, Kapocius L, Tatarunas V, Gecys D, Mickiene A, Tamosuitis T, et al.
Pharmaceutics
. 2024 Mar;
16(3).
PMID: 38543303
The study presents data on the anti-inflammatory effects of a combination of sodium dichloroacetate and sodium valproate (DCA-VPA) on the expression of inflammation- and immune response-related genes in T lymphocytes...
4.
Stakisaitis D, Kapocius L, Kilimaite E, Gecys D, Slekiene L, Balnyte I, et al.
Pharmaceutics
. 2023 Dec;
15(12).
PMID: 38140056
The research presents data from a preclinical study on the anti-inflammatory effects of a sodium dichloroacetate and sodium valproate combination (DCA-VPA). The 2-week treatment with a DCA 100 mg/kg/day and...
5.
Gecys D, Skredeniene R, Gecyte E, Kazlauskas A, Balnyte I, Jekabsone A
Cells
. 2023 May;
12(9).
PMID: 37174646
Extracellular vesicles (EVs) are attractive anticancer drug delivery candidates as they confer several fundamental properties, such as low immunogenicity and the ability to cross biological barriers. Mesenchymal stem cells (MSCs)...
6.
Damanskiene E, Balnyte I, Valanciute A, Lesauskaite V, Alonso M, Stakisaitis D
Int J Mol Sci
. 2022 Sep;
23(18).
PMID: 36142368
In this study, pyruvate dehydrogenase kinase-1 inhibition with dichloroacetate (DCA) was explored as an alternative cancer therapy. The study's aim was to compare the effectiveness of NaDCA and MgDCA on...
7.
Dirziuviene R, Slekiene L, Palubinskiene J, Balnyte I, Lasiene K, Stakisaitis D, et al.
Histol Histopathol
. 2022 Jun;
37(12):1201-1212.
PMID: 35703146
Lung cancer is the most frequent cause of cancer death. Some human lung malignant tumors have a combined small-cell lung cancer (SCLC) and non-small-cell lung cancer (NSCLC) histology, with tumor...
8.
Damanskiene E, Balnyte I, Valanciute A, Alonso M, Stakisaitis D
Biomedicines
. 2022 May;
10(5).
PMID: 35625705
Valproic acid (VPA) is a histone deacetylase inhibitor with sex-specific immunomodulatory and anticancer effects. This study aimed to investigate the effect of 0.5 and 0.75 mM VPA on NKCC1 (),...
9.
Stakisaitis D, Kapocius L, Valanciute A, Balnyte I, Tamosuitis T, Vaitkevicius A, et al.
Biomedicines
. 2022 May;
10(5).
PMID: 35625699
Sex differences identified in the COVID-19 pandemic are necessary to study. It is essential to investigate the efficacy of the drugs in clinical trials for the treatment of COVID-19, and...
10.
Damanskiene E, Balnyte I, Valanciute A, Alonso M, Preiksaitis A, Stakisaitis D
Int J Mol Sci
. 2022 Feb;
23(4).
PMID: 35216113
It is necessary to elucidate the individual effects of temozolomide (TMZ) on carcinogenesis and tumor resistance to chemotherapy mechanisms. The study aimed to investigate the TMZ 50 and 100 μM...